Loading…
Reported covered position: Snr. Legislative Assistant, Rep. Diane Black (Jan. - Nov. 2015); Healthcare Legislative Assistant, Rep. Michael Burgess (April 2014 - Jan. 2015)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Good Jobs for Good Airports Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Good Jobs for Good Airports Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · third_quarter · Q3
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Source: Senate LDA
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Chronic Disease Flexible Coverage Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.
INSULIN Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
SCREEN for Type 1 Diabetes Act of 2024
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
S. 4690 / H.R. 9027, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025 S. 4942 / H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Affordable Insulin Now Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-S. 4504 / H.R 8698 - SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes) -S. 1855 - Special Diabetes Program Reauthorization Act of 2023 -S. 1269 - INSULIN Act of 2023 -H.R 1499 - Affordable Insulin Now Act -S. 954 - Affordable Insulin Now Act of 2023 -H.R. 3800 - Chronic Disease Flexible Coverage Act -Issues related to cell and gene therapies
Affordable Insulin Now Act of 2023
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) · Firm: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · second_quarter · Q2
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
2024 · first_quarter · Q1
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE